Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Market Cap

Rigel Pharmaceuticals Market Cap Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Market Cap from 2010 to 2020. Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.
  • Rigel Pharmaceuticals Market Cap for the quarter ending November 11, 2020 was $526m a 8.04% increase of 42m year over year
  • Rigel Pharmaceuticals Market Cap for the last 12 months ending November 11, 2020 was $526m a 8.04% increase of 42m year over year
  • Rigel Pharmaceuticals Annual Market Cap for 2020 was $526m a 5.79% increase of 30m from 2019
  • Rigel Pharmaceuticals Annual Market Cap for 2020 was $495m a 0.34% increase of 2m from 2019
  • Rigel Pharmaceuticals Annual Market Cap for 2020 was $493m a 2.05% increase of 10m from 2019
Other Valuation Metrics:
  • Rigel Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 5.16 a 23.02% increase of 1.19 year over year
  • Rigel Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $406m a 41.78% increase of 169m year over year
View Chart On Koyfin

Quarterly RIGL Market Cap Data

11/2020$526m
11/2020$495m
11/2020$493m
11/2020$483m
11/2020$465m
11/2020$460m
11/2020$451m
11/2020$465m
11/2020$463m
11/2020$465m

Annual RIGL Market Cap Data

2020$526m
2020$495m
2020$493m
2020$483m
2020$465m
2020$460m
2020$451m
2020$465m
2020$463m
2020$465m